Go Pro

Concorde International Group (CIGL) Financials

$0.46 -0.01 (-2.12%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$0.45 -0.01 (-2.08%)
As of 07/24/2026 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Concorde International Group

Annual Income Statements for Concorde International Group

This table shows Concorde International Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-0.80 1.06 -167 -4.18
Consolidated Net Income / (Loss)
-0.80 1.06 -84 -4.18
Net Income / (Loss) Continuing Operations
-0.80 1.06 -84 -4.18
Total Pre-Tax Income
-0.80 1.06 -84 -4.18
Total Operating Income
0.06 1.35 -83 0.32
Total Gross Profit
1.36 2.99 3.62 3.85
Total Revenue
5.01 11 10 12
Operating Revenue
5.01 11 10 12
Total Cost of Revenue
3.65 7.66 8.13 8.63
Operating Cost of Revenue
3.65 7.66 8.13 8.63
Total Operating Expenses
1.30 1.64 86 3.53
Depreciation Expense
0.39 0.33 0.28 0.59
Other Operating Expenses / (Income)
0.91 1.31 - 2.94
Total Other Income / (Expense), net
-0.86 -0.30 -0.22 -4.50
Other Income / (Expense), net
-0.86 -0.30 - -4.50
Weighted Average Basic Shares Outstanding
- - 20.89M 26.99M
Diluted Earnings per Share
($7.83) $9.61 ($5.08) ($0.67)
Weighted Average Diluted Shares Outstanding
- - 20.89M 26.99M
Weighted Average Basic & Diluted Shares Outstanding
- - 20.89M 26.99M

Quarterly Income Statements for Concorde International Group

No quarterly income statements for Concorde International Group are available.


Annual Cash Flow Statements for Concorde International Group

This table details how cash moves in and out of Concorde International Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-2.17 0.48 0.62 0.54
Net Cash From Operating Activities
-1.01 0.79 0.62 -3.52
Net Cash From Continuing Operating Activities
-1.01 0.79 0.62 -3.53
Net Income / (Loss) Continuing Operations
0.00 1.13 0.00 -15
Consolidated Net Income / (Loss)
- 1.13 - -15
Depreciation Expense
0.31 0.24 - 0.59
Amortization Expense
0.08 0.09 0.05 0.00
Non-Cash Adjustments To Reconcile Net Income
-0.52 0.12 0.56 11
Changes in Operating Assets and Liabilities, net
-0.88 -0.78 - -0.11
Net Cash From Investing Activities
-0.91 -0.31 0.00 -0.12
Net Cash From Continuing Investing Activities
-0.91 -0.41 0.00 -0.19
Purchase of Property, Plant & Equipment
0.00 -0.41 - -0.19
Net Cash From Financing Activities
0.60 0.00 0.00 4.17
Net Cash From Continuing Financing Activities
0.60 0.00 0.00 5.08
Repayment of Debt
-0.51 -2.04 - -0.67
Issuance of Debt
1.12 2.04 - 0.00
Issuance of Common Equity
0.00 0.00 - 5.75

Quarterly Cash Flow Statements for Concorde International Group

No quarterly cash flow statements for Concorde International Group are available.


Annual Balance Sheets for Concorde International Group

This table presents Concorde International Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets
8.55 10 11
Total Current Assets
5.29 4.95 6.79
Cash & Equivalents
0.96 1.00 1.63
Accounts Receivable
3.49 3.95 5.16
Plant, Property, & Equipment, net
2.90 3.72 3.63
Plant, Property & Equipment, gross
- 3.72 3.63
Total Noncurrent Assets
0.36 1.16 0.85
Intangible Assets
0.07 0.01 0.01
Other Noncurrent Operating Assets
0.29 1.15 0.84
Total Liabilities & Shareholders' Equity
8.55 10 11
Total Liabilities
5.85 8.01 7.57
Total Current Liabilities
3.51 4.58 5.31
Short-Term Debt
1.86 3.12 2.89
Accounts Payable
1.19 1.31 2.13
Current Deferred & Payable Income Tax Liabilities
0.00 0.06 0.19
Other Current Liabilities
0.47 0.09 0.10
Total Noncurrent Liabilities
2.33 3.43 2.26
Long-Term Debt
- 3.08 1.92
Capital Lease Obligations
0.09 0.17 0.20
Noncurrent Deferred & Payable Income Tax Liabilities
0.13 0.18 0.14
Total Equity & Noncontrolling Interests
2.70 2.26 3.70
Total Preferred & Common Equity
2.57 2.11 3.59
Total Common Equity
2.57 2.11 3.59
Common Stock
0.00 0.00 100
Retained Earnings
0.18 -83 -98
Other Equity Adjustments
2.39 85 2.45
Noncontrolling Interest
0.14 0.15 0.11

Quarterly Balance Sheets for Concorde International Group

No quarterly balance sheets for Concorde International Group are available.


Annual Metrics And Ratios for Concorde International Group

This table displays calculated financial ratios and metrics derived from Concorde International Group's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 0.00 0.00
DEI Adjusted Shares Outstanding
0.00 0.00 0.00 0.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00 0.00
Growth Metrics
- - - -
Revenue Growth
0.00% 112.85% -1.55% 18.92%
EBITDA Growth
0.00% 434.24% -6,103.10% 95.69%
EBIT Growth
0.00% 231.31% -7,983.94% 94.98%
NOPAT Growth
0.00% 3,382.90% -4,406.66% 100.39%
Net Income Growth
0.00% 231.31% -8,021.32% 95.00%
EPS Growth
0.00% 222.73% -152.86% 86.81%
Operating Cash Flow Growth
0.00% 178.34% -21.90% -669.24%
Free Cash Flow Firm Growth
0.00% 0.00% -2,531.92% 100.53%
Invested Capital Growth
0.00% 0.00% 94.22% -1.43%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - -
Gross Margin
27.12% 28.10% 34.46% 30.84%
EBITDA Margin
-8.28% 13.00% -792.83% -28.76%
Operating Margin
1.11% 12.70% -793.36% 2.58%
EBIT Margin
-16.06% 9.91% -793.36% -33.49%
Profit (Net Income) Margin
-16.06% 9.91% -797.12% -33.49%
Tax Burden Percent
100.00% 100.00% 100.14% 100.00%
Interest Burden Percent
100.00% 100.00% 100.34% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 73.15% -1,070.69% 3.16%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 13.50% -1,927.57% -102.86%
Return on Net Nonoperating Assets (RNNOA)
0.00% 4.98% -2,299.32% -143.35%
Return on Equity (ROE)
0.00% 78.12% -3,370.02% -140.19%
Cash Return on Invested Capital (CROIC)
0.00% -126.85% -1,134.74% 4.59%
Operating Return on Assets (OROA)
0.00% 12.35% -884.29% -38.79%
Return on Assets (ROA)
0.00% 12.35% -888.48% -38.79%
Return on Common Equity (ROCE)
0.00% 74.15% -3,173.79% -133.98%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
0.04 1.35 -58 0.23
NOPAT Margin
0.78% 12.70% -555.35% 1.80%
Net Nonoperating Expense Percent (NNEP)
0.00% 59.65% 856.88% 106.02%
Return On Investment Capital (ROIC_SIMPLE)
- 29.06% -674.83% 2.58%
Cost of Revenue to Revenue
72.88% 71.90% 77.52% 69.16%
SG&A Expenses to Revenue
0.00% 0.00% 813.17% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
26.01% 15.40% 815.84% 28.26%
Earnings before Interest and Taxes (EBIT)
-0.80 1.06 -83 -4.18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.41 1.39 -83 -3.59
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 1.95 2.37 12.11
Price to Tangible Book Value (P/TBV)
0.00 2.00 2.38 12.14
Price to Revenue (P/Rev)
1.00 0.47 0.48 3.48
Price to Earnings (P/E)
0.00 4.74 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 21.11% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.66 1.47 6.63
Enterprise Value to Revenue (EV/Rev)
0.00 0.58 1.00 3.76
Enterprise Value to EBITDA (EV/EBITDA)
0.00 4.43 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 5.81 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 4.53 0.00 208.58
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 7.75 17.04 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 143.29
Leverage & Solvency
- - - -
Debt to Equity
0.00 0.72 2.82 1.35
Long-Term Debt to Equity
0.00 0.03 1.44 0.57
Financial Leverage
0.00 0.37 1.19 1.39
Leverage Ratio
0.00 3.16 3.79 3.61
Compound Leverage Factor
0.00 3.16 3.81 3.61
Debt to Total Capital
0.00% 41.95% 73.82% 57.53%
Short-Term Debt to Total Capital
0.00% 40.02% 36.17% 33.14%
Long-Term Debt to Total Capital
0.00% 1.93% 37.65% 24.39%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 2.95% 1.76% 1.29%
Common Equity to Total Capital
0.00% 55.10% 24.42% 41.18%
Debt to EBITDA
0.00 1.41 -0.08 -1.40
Net Debt to EBITDA
0.00 0.72 -0.06 -0.94
Long-Term Debt to EBITDA
0.00 0.07 -0.04 -0.59
Debt to NOPAT
0.00 1.44 -0.11 22.27
Net Debt to NOPAT
0.00 0.74 -0.09 15.03
Long-Term Debt to NOPAT
0.00 0.07 -0.06 9.44
Altman Z-Score
0.00 2.44 -36.65 -8.75
Noncontrolling Interest Sharing Ratio
0.00% 5.08% 5.82% 4.43%
Liquidity Ratios
- - - -
Current Ratio
0.00 1.50 1.08 1.28
Quick Ratio
0.00 1.26 1.08 1.28
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 -2.35 -62 0.33
Operating Cash Flow to CapEx
0.00% 191.97% 0.00% -1,882.09%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 -282.42 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 2.83 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 2.83 0.00
Efficiency Ratios
- - - -
Asset Turnover
0.00 1.25 1.11 1.16
Accounts Receivable Turnover
0.00 3.06 2.82 2.74
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 3.67 3.17 3.40
Accounts Payable Turnover
0.00 6.46 6.52 5.02
Days Sales Outstanding (DSO)
0.00 119.38 129.28 133.27
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 56.51 55.98 72.78
Cash Conversion Cycle (CCC)
0.00 62.87 73.31 60.49
Capital & Investment Metrics
- - - -
Invested Capital
0.00 3.70 7.18 7.08
Invested Capital Turnover
0.00 5.76 1.93 1.75
Increase / (Decrease) in Invested Capital
0.00 3.70 3.49 -0.10
Enterprise Value (EV)
0.00 6.13 11 47
Market Capitalization
5.00 5.00 5.00 43
Book Value per Share
$0.00 $2.05 $0.10 $0.13
Tangible Book Value per Share
$0.00 $2.00 $0.10 $0.13
Total Capital
0.00 4.66 8.63 8.71
Total Debt
0.00 1.95 6.37 5.01
Total Long-Term Debt
0.00 0.09 3.25 2.12
Net Debt
0.00 1.00 5.37 3.38
Capital Expenditures (CapEx)
0.00 0.41 0.00 0.19
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 2.68 2.49 2.74
Debt-free Net Working Capital (DFNWC)
0.00 3.64 3.49 4.37
Net Working Capital (NWC)
0.00 1.77 0.37 1.48
Net Nonoperating Expense (NNE)
0.84 0.30 25 4.40
Net Nonoperating Obligations (NNO)
0.00 1.00 4.92 3.38
Total Depreciation and Amortization (D&A)
0.39 0.33 0.05 0.59
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 25.14% 23.72% 21.98%
Debt-free Net Working Capital to Revenue
0.00% 34.12% 33.26% 35.04%
Net Working Capital to Revenue
0.00% 16.63% 3.49% 11.90%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($5.08) $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 20.89M 26.99M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($5.08) ($0.67)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 20.89M 26.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 20.89M 26.99M
Normalized Net Operating Profit after Tax (NOPAT)
0.04 0.95 -58 0.23
Normalized NOPAT Margin
0.78% 8.89% -555.35% 1.80%
Pre Tax Income Margin
-16.06% 9.91% -796.02% -33.49%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.00 0.00 -380.68 0.00
NOPAT to Interest Expense
0.00 0.00 -266.48 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 -380.68 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 -266.48 0.00
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Concorde International Group

No quarterly metrics and ratios for Concorde International Group are available.



Financials Breakdown Chart

Concorde International Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Concorde International Group's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Concorde International Group's net income appears to be on an upward trend, with a most recent value of -$4.18 million in 2025, rising from -$803.98 thousand in 2022. The previous period was -$83.62 million in 2024. View Concorde International Group's forecast to see where analysts expect Concorde International Group to go next.

Concorde International Group's total operating income in 2025 was $321.50 thousand, based on the following breakdown:
  • Total Gross Profit: $3.85 million
  • Total Operating Expenses: $3.53 million

Over the last 3 years, Concorde International Group's total revenue changed from $5.01 million in 2022 to $12.48 million in 2025, a change of 149.2%.

Concorde International Group's total liabilities were at $7.57 million at the end of 2025, a 5.5% decrease from 2024, and a 29.4% increase since 2023.

In the past 2 years, Concorde International Group's cash and equivalents has ranged from $956.98 thousand in 2023 to $1.63 million in 2025, and is currently $1.63 million as of their latest financial filing in 2025.

Over the last 3 years, Concorde International Group's book value per share changed from 0.00 in 2022 to 0.13 in 2025, a change of 13.3%.



Financial statements for NASDAQ:CIGL last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners